Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?

Схожие документы

• Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?
  по: Ramachandran, S, et al.
  Опубликовано: (2000)
• Lipid lowering drugs in diabetes: Absolute risk reduction is what counts
  по: Lewis, L S
  Опубликовано: (2006)
• Risk in cardiovascular disease : Merit of using risk reduction rather than absolute risk for lipid lowering drugs
  по: Neary, Richard, et al.
  Опубликовано: (2000)
• Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community
  по: Lieb, Wolfgang, et al.
  Опубликовано: (2018)
• Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
  по: Alderman, Michael H., et al.
  Опубликовано: (2015)